| RESEARCH ARTICLE |
|
| Year : 2012 | Volume
: 24
| Issue : 1 | Page : 20-23 |
|
|
Dapsone in the treatment of resistant oral erosive lichen planus: A clinical study
AC Raj1, KT Sreelatha2, Anita Balan3
1 Professor, Department of Oral Medicine and Radiology, KVG Dental College, Sullia, Karnataka, India
2 Principal, Department of Oral Medicine and Radiology, Al Azhar Dental College, Thodupuzha, Kerala, India
3 Professor and Head, Department of Oral Medicine and Radiology Government Dental College, Calicut, Kerala, India
Correspondence Address:
A C Raj
Professor, Department of Oral Medicine and Radiology, KVG Dental College, Sullia, Karnataka
India
 Source of Support: None, Conflict of Interest: None  | Check |
|
|
|
Aims: This study was designed to evaluate the efficacy of Dapsone for treating erosive lichen planus and to observe side effects occurring for the drug during the treatment.
Materials and methods: Twenty-two patients who were resistant to treatment with systemic antioxidants and topical vitamin were treated with systemic Dapsone 100 mg per day for 3 months. Improvement of signs and symptoms of the disease and the side effects of the drug were evaluated every 15 days and posttreatment recurrence of the disease was assessed after 6 months of treatment.
Results: A significant improvement in the burning sensation and reduction in size of the erosive areas were noticed with a 3 months course of Dapsone therapy. Systemic side effects were minimal. A reduction in hemoglobin percentage of 0.92 gm from the baseline values was the only observed side effect
Conclusion: Results of this study show that Dapsone is an effective drug in erosive lichen planus. Dapsone can be used as a steroid sparing agent when steroids are contraindicated. There are minimal side effects for Dapsone when used in the dose of 100 mg per day for 3 months. |
|
|
|
| [PDF]* |
|
 |
|
